ITUS Corporation to Present at WallStreet Research Hosted Event on May 31 in Los Angeles

LOS ANGELES, CA -- (Marketwired) -- 05/30/17 -- ITUS Corporation ("ITUS") (NASDAQ: ITUS), a company using the power of the immune system to diagnose cancer, today announced that it will present at an investor event hosted by WallStreet Research in Los Angeles on May 31, 2017. The event will be held at Skylight Gardens in Westwood, with registration for the event beginning at 12:30 pm Pacific Time.

WallStreet Research, which specializes in bringing undervalued companies to the attention of the investment community, hosts investor events in select cities throughout the U.S. and provides investment research and capital markets analysis for emerging growth companies.

ITUS Corporation

ITUS is developing a platform called Cchek™, a series of non-invasive, blood tests for the early detection of solid tumor based cancers, which is based on the body's immunological response to the presence of a malignancy. Additional information is available at www.ITUScorp.com.

Forward-Looking Statements: Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect ITUS Corporation's current expectations concerning future events and results. We generally use the words "believes," "expects," "intends," "plans," "anticipates," "likely," "will" and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in "Item 1A -- Risk Factors" and other sections of our Annual Report on Form 10-K for the fiscal year ended October 31, 2016 as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this press release.

Contact:
Mike Catelani
(310) 484-5200
MCatelani@ITUScorp.com
ITUS Corporation: FOCUSED ON INNOVATION™

Source: ITUS Corporation

Released May 30, 2017